Cargando…

Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention

BACKGROUND: Access site complications contribute to morbidity and mortality during percutaneous coronary intervention (PCI). Transradial arterial access significantly lowers the risk of access site complications compared to transfemoral arteriotomy. We sought to develop a prediction model for access...

Descripción completa

Detalles Bibliográficos
Autores principales: Wimmer, Neil J., Resnic, Frederic S., Mauri, Laura, Matheny, Michael E., Piemonte, Thomas C., Pomerantsev, Eugene, Ho, Kalon K. L., Robbins, Susan L., Waldman, Howard M., Yeh, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698780/
https://www.ncbi.nlm.nih.gov/pubmed/23709565
http://dx.doi.org/10.1161/JAHA.113.000174
_version_ 1782275333280497664
author Wimmer, Neil J.
Resnic, Frederic S.
Mauri, Laura
Matheny, Michael E.
Piemonte, Thomas C.
Pomerantsev, Eugene
Ho, Kalon K. L.
Robbins, Susan L.
Waldman, Howard M.
Yeh, Robert W.
author_facet Wimmer, Neil J.
Resnic, Frederic S.
Mauri, Laura
Matheny, Michael E.
Piemonte, Thomas C.
Pomerantsev, Eugene
Ho, Kalon K. L.
Robbins, Susan L.
Waldman, Howard M.
Yeh, Robert W.
author_sort Wimmer, Neil J.
collection PubMed
description BACKGROUND: Access site complications contribute to morbidity and mortality during percutaneous coronary intervention (PCI). Transradial arterial access significantly lowers the risk of access site complications compared to transfemoral arteriotomy. We sought to develop a prediction model for access site complications in patients undergoing PCI with femoral arteriotomy, and assess whether transradial access was selectively used in patients at high risk for complications. METHODS AND RESULTS: We analyzed 17 509 patients who underwent PCI without circulatory support from 2008 to 2011 at 5 institutions. Transradial arterial access was used in 17.8% of patients. In those who underwent transfemoral access, 177 (1.2%) patients had access site complications. Using preprocedural clinical and demographic data, a prediction model for femoral arteriotomy complications was generated. The variables retained in the model included: elevated age (P<0.001), female gender (P<0.001), elevated troponin (P<0.001), decreased renal function or dialysis (P=0.002), emergent PCI (P=0.01), prior PCI (P=0.005), diabetes (P=0.008), and peripheral artery disease (P=0.003). The model showed moderate discrimination (optimism‐adjusted c‐statistic=0.72) and was internally validated via bootstrap resampling. Patients with higher predicted risk of complications via transfemoral access were less likely to receive transradial access (P<0.001). Similar results were seen in patients presenting with and without ST‐segment myocardial infarction and when adjusting for individual physician operator. CONCLUSIONS: We generated and validated a model for transfemoral access site complications during PCI. Paradoxically, patients most likely to develop access site complications from transfemoral access, and therefore benefit from transradial access, were the least likely to receive transradial access.
format Online
Article
Text
id pubmed-3698780
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-36987802013-09-03 Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention Wimmer, Neil J. Resnic, Frederic S. Mauri, Laura Matheny, Michael E. Piemonte, Thomas C. Pomerantsev, Eugene Ho, Kalon K. L. Robbins, Susan L. Waldman, Howard M. Yeh, Robert W. J Am Heart Assoc Original Research BACKGROUND: Access site complications contribute to morbidity and mortality during percutaneous coronary intervention (PCI). Transradial arterial access significantly lowers the risk of access site complications compared to transfemoral arteriotomy. We sought to develop a prediction model for access site complications in patients undergoing PCI with femoral arteriotomy, and assess whether transradial access was selectively used in patients at high risk for complications. METHODS AND RESULTS: We analyzed 17 509 patients who underwent PCI without circulatory support from 2008 to 2011 at 5 institutions. Transradial arterial access was used in 17.8% of patients. In those who underwent transfemoral access, 177 (1.2%) patients had access site complications. Using preprocedural clinical and demographic data, a prediction model for femoral arteriotomy complications was generated. The variables retained in the model included: elevated age (P<0.001), female gender (P<0.001), elevated troponin (P<0.001), decreased renal function or dialysis (P=0.002), emergent PCI (P=0.01), prior PCI (P=0.005), diabetes (P=0.008), and peripheral artery disease (P=0.003). The model showed moderate discrimination (optimism‐adjusted c‐statistic=0.72) and was internally validated via bootstrap resampling. Patients with higher predicted risk of complications via transfemoral access were less likely to receive transradial access (P<0.001). Similar results were seen in patients presenting with and without ST‐segment myocardial infarction and when adjusting for individual physician operator. CONCLUSIONS: We generated and validated a model for transfemoral access site complications during PCI. Paradoxically, patients most likely to develop access site complications from transfemoral access, and therefore benefit from transradial access, were the least likely to receive transradial access. Blackwell Publishing Ltd 2013-06-21 /pmc/articles/PMC3698780/ /pubmed/23709565 http://dx.doi.org/10.1161/JAHA.113.000174 Text en © 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley-Blackwell. http://creativecommons.org/licenses/by/2.5/ This is an Open Access article under the terms of the Creative Commons Attribution Noncommercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Wimmer, Neil J.
Resnic, Frederic S.
Mauri, Laura
Matheny, Michael E.
Piemonte, Thomas C.
Pomerantsev, Eugene
Ho, Kalon K. L.
Robbins, Susan L.
Waldman, Howard M.
Yeh, Robert W.
Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title_full Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title_fullStr Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title_full_unstemmed Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title_short Risk‐Treatment Paradox in the Selection of Transradial Access for Percutaneous Coronary Intervention
title_sort risk‐treatment paradox in the selection of transradial access for percutaneous coronary intervention
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698780/
https://www.ncbi.nlm.nih.gov/pubmed/23709565
http://dx.doi.org/10.1161/JAHA.113.000174
work_keys_str_mv AT wimmerneilj risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT resnicfrederics risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT maurilaura risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT mathenymichaele risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT piemontethomasc risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT pomerantseveugene risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT hokalonkl risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT robbinssusanl risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT waldmanhowardm risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention
AT yehrobertw risktreatmentparadoxintheselectionoftransradialaccessforpercutaneouscoronaryintervention